Texas SB2257 amends the definition of an abortion-inducing drug and sets new requirements for physicians before providing such drugs.

Texas SB2257 amends the Health and Safety Code to redefine "abortion-inducing drug" as any substance intended to terminate a pregnancy, including off-label use of drugs like Mifeprex and misoprostol. It excludes drugs used for other medical reasons. The bill mandates that before providing an abortion-inducing drug, a physician must examine the woman, verify the pregnancy, document gestational age and location, check for ectopic pregnancy, determine blood type, offer Rh immunoglobulin for Rh-negative women, and confirm no treatment for Rh negativity.

Texas SB2257 amends the definition of an abortion-inducing drug and sets new requirements for physicians before providing such drugs.

Texas SB2257 amends the Health and Safety Code to redefine "abortion-inducing drug" as any substance intended to terminate a pregnancy, including off-label use of drugs like Mifeprex and misoprostol. It excludes drugs used for other medical reasons. The bill mandates that before providing an abortion-inducing drug, a physician must examine the woman, verify the pregnancy, document gestational age and location, check for ectopic pregnancy, determine blood type, offer Rh immunoglobulin for Rh-negative women, and confirm no treatment for Rh negativity.